Evidence map›Paper›PMID 42738674›Full record

ArticleMolecules (Basel, Switzerland)2026

Bumetanide/Synthetic Saponite Composites: Performant Systems for Enhanced Drug Dissolution Rate.

Valeria Friuli, Doretta Capsoni, Lauretta Maggi, Giovanna Bruni, Elena Cassera, Claudia Urru

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Valeria FriuliDepartment of Drug Sciences, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy.ORCID 0000-0002-2975-4362
Doretta CapsoniDepartment of Chemistry, Physical Chemistry Section & C.S.G.I. (Consorzio Interuniversitario per lo Sviluppo dei Sistemi a Grande Interfase), University of Pavia, Via Taramelli 12, 27100 Pavia, Italy.ORCID 0000-0002-1064-7196
Lauretta MaggiDepartment of Drug Sciences, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy.ORCID 0000-0002-1408-8846
Giovanna BruniDepartment of Chemistry, Physical Chemistry Section & C.S.G.I. (Consorzio Interuniversitario per lo Sviluppo dei Sistemi a Grande Interfase), University of Pavia, Via Taramelli 12, 27100 Pavia, Italy.ORCID 0000-0003-1958-2998
Elena CasseraDepartment of Chemistry, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy.ORCID 0009-0004-1967-4811
Claudia UrruDepartment of Chemistry, Physical Chemistry Section & C.S.G.I. (Consorzio Interuniversitario per lo Sviluppo dei Sistemi a Grande Interfase), University of Pavia, Via Taramelli 12, 27100 Pavia, Italy.ORCID 0009-0005-9900-6203

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bumetanide is an efficient diuretic drug with poor water solubility and dissolution rate. In this study, bumetanide/synthetic saponite systems with enhanced solubility and dissolution rate are developed. Different synthetic strategies (hydrothermal and sol-gel) and aluminum contents are explored to prepare saponites with adjustable stacking. Bumetanide loading is achieved by a solution method. The synthetic route is feasible and scalable. Crystalline and non-crystalline bumetanide co-exist in the hybrids, and the non-crystalline fraction prevails in stacked saponite-based composites. Electrostatic interaction occurs between the negatively charged smectite layers and the protonated anilinic group, and the molecules accommodate within the interlayer spacing of stacked saponites. Compared with bumetanide, all the composites improve water solubility, wettability, and dissolution rate in simulated gastric conditions (pH 1.2 and 4.5) and deionized water. The samples with drug intercalation and a reduced fraction of crystalline bumetanide are the best-performing. The drug release is favoured at pH ≥ 4.5, as electrostatic repulsion occurs between the saponite layers and the carboxylate group of bumetanide. The complete release of the bumetanide dose, not achieved in sufficiently short times for all the fluids considered, is reached in the formulation with appropriate excipients. Bumetanide/saponite composites revealed performant and tuneable systems for bumetanide solubility and dissolution rate enhancement.

Indexed as

BumetanideAluminum SilicatesDrug LiberationHydrogen-Ion ConcentrationSilicatesSolubilityWaterWettabilityAluminum SilicatesBumetanidesaponiteSilicatesWaterbumetanidedissolution testdrug–clay hybridspoor water solubilitysolid-state characterizationsynthetic saponite

Identifiers

PMID42738674
PMCPMC13567011

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.